Guardant Health Inc (NASDAQ: GH) on Tuesday, soared 23.10% from the previous trading day, before settling in for the closing price of $36.66. Within the past 52 weeks, GH’s price has moved between $15.81 and $39.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 27.46%. The company achieved an average annual earnings per share of 21.94%. With a float of $117.73 million, this company’s outstanding shares have now reached $123.16 million.
Let’s determine the extent of company efficiency that accounts for 1779 employees. In terms of profitability, gross margin is 81.07%, operating margin of -74.41%, and the pretax margin is -74.02%.
Guardant Health Inc (GH) Breakdown of a Key Holders of the stock
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Guardant Health Inc is 4.72%, while institutional ownership is 103.02%. The most recent insider transaction that took place on Jan 17 ’25, was worth 4,359. In this transaction Director of this company sold 116 shares at a rate of $37.58, taking the stock ownership to the 2,944 shares. Before that another transaction happened on Jan 17 ’25, when Company’s Director proposed sale 116 for $37.58, making the entire transaction worth $4,359.
Guardant Health Inc (GH) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.00% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Guardant Health Inc (GH) is currently performing well based on its current performance indicators. A quick ratio of 5.85 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.24, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.92 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 2.71 million, which is a jump from its year-to-date volume of 2.53 million. As of the previous 9 days, the stock’s Stochastic %D was 66.70%. Additionally, its Average True Range was 2.34.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 97.85%, which indicates a significant increase from 96.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.46% in the past 14 days, which was higher than the 63.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.63, while its 200-day Moving Average is $27.29. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $47.77. Second resistance stands at $50.40. The third major resistance level sits at $55.13. If the price goes on to break the first support level at $40.41, it is likely to go to the next support level at $35.68. Now, if the price goes above the second support level, the third support stands at $33.05.
Guardant Health Inc (NASDAQ: GH) Key Stats
Market capitalization of the company is 5.58 billion based on 123,555K outstanding shares. Right now, sales total 563,950 K and income totals -479,450 K. The company made 191,480 K in profit during its latest quarter, and -107,750 K in sales during its previous quarter.
